• Account Access
  • Contact Us

    Pre-Sales Support

    Mutual Funds and ETFs - 800-456-7526
    Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
    Friday: 8:00 a.m. – 5:00 p.m. ET

    ETF Trading Support - 415-315-6600
    Monday-Friday: 9:30 a.m. – 5:00 p.m. ET

    Post-Sales and Website Support
    888-843-7824
    Monday-Friday: 9:00 a.m. - 6:00 p.m. ET

  • Advisor Log In

Hartford Healthcare Fund

addandremoveFav

Explore Another ETFs

Objective

Seeks long-term capital appreciation.

Overview

A stock fund that invests exclusively in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

More About Healthcare Fund 

The Health-Care Revolution

The health-care sector is undergoing dramatic changes that will impact everything from the drugs we take to the way patients’ medical records are shared. Aging demographics globally and rising prosperity in emerging-market nations will drive even greater demand for lifesaving drugs, innovative procedures, and disruptive medical technology.

Pipeline to Innovation

With innovation and breakthroughs taking place across the globe, the Fund uses a broadly diversified, global approach that seeks to identify companies with the greatest opportunities in areas including biotechnology, medical technology, health services, and pharmaceuticals.

Backed by Size, Scale, and Experience

Wellington Management, the Fund’s sub-adviser, is one of the largest managers of health care stocks in the world. The portfolio managers on the Fund average 26 years of experience.


Jean M. Hynes, CFA
Senior Managing Director
Global Industry Analyst
Ann C. Gallo
Senior Managing Director
Global Industry Analyst
Robert L. Deresiewicz
Senior Managing Director
Global Industry Analyst

The portfolio managers are supported by the full resources of Wellington.

Performance

Performance (%)
% (as of 5/31/2019)
Average Annual Total Returns % (as of 5/31/2019)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare  I 7.84 -0.66 7.91 9.30 15.67 11.16
Benchmark 1.48 6.65 9.27 10.08 15.58 ---
Morningstar Health Category 4.91 -1.81 7.98 8.58 15.24 ---
Performance (%)
% (as of 3/31/2019)
Average Annual Total Returns % (as of 3/31/2019)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare  I 14.15 9.24 12.32 10.63 17.35 11.60
Benchmark 6.89 14.63 13.06 11.72 16.92 ---
Morningstar Health Category 12.85 10.67 13.02 10.09 16.79 ---
SI = Since Inception. Fund Inception: 05/01/2000
Operating Expenses:   Net  1.00% |  Gross  1.00%
Share Class Inception: 8/31/06.
Class I-share performance prior to its inception date reflects Class A-share performance (excluding sales charges) and operating expenses. SI performance is calculated from 5/1/00.

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Growth of $10,000 (I-Share)

(as of 4/30/2019)
[{"date":"Tue Apr 30 00:00:00 EDT 2019","value":"47861.0"},{"date":"Sun Mar 31 00:00:00 EDT 2019","value":"48956.0"},{"date":"Thu Feb 28 00:00:00 EST 2019","value":"48402.0"},{"date":"Thu Jan 31 00:00:00 EST 2019","value":"47024.0"},{"date":"Mon Dec 31 00:00:00 EST 2018","value":"42889.0"},{"date":"Fri Nov 30 00:00:00 EST 2018","value":"47450.0"},{"date":"Wed Oct 31 00:00:00 EDT 2018","value":"45316.0"},{"date":"Sun Sep 30 00:00:00 EDT 2018","value":"50838.0"},{"date":"Fri Aug 31 00:00:00 EDT 2018","value":"50813.0"},{"date":"Tue Jul 31 00:00:00 EDT 2018","value":"48516.0"},{"date":"Sat Jun 30 00:00:00 EDT 2018","value":"46521.0"},{"date":"Thu May 31 00:00:00 EDT 2018","value":"46558.0"},{"date":"Mon Apr 30 00:00:00 EDT 2018","value":"44488.0"},{"date":"Sat Mar 31 00:00:00 EDT 2018","value":"44814.0"},{"date":"Wed Feb 28 00:00:00 EST 2018","value":"45304.0"},{"date":"Wed Jan 31 00:00:00 EST 2018","value":"47048.0"},{"date":"Sun Dec 31 00:00:00 EST 2017","value":"44099.0"},{"date":"Thu Nov 30 00:00:00 EST 2017","value":"44288.0"},{"date":"Tue Oct 31 00:00:00 EDT 2017","value":"43511.0"},{"date":"Sat Sep 30 00:00:00 EDT 2017","value":"44753.0"},{"date":"Thu Aug 31 00:00:00 EDT 2017","value":"44646.0"},{"date":"Mon Jul 31 00:00:00 EDT 2017","value":"44192.0"},{"date":"Fri Jun 30 00:00:00 EDT 2017","value":"44085.0"},{"date":"Wed May 31 00:00:00 EDT 2017","value":"41744.0"},{"date":"Sun Apr 30 00:00:00 EDT 2017","value":"41385.0"},{"date":"Fri Mar 31 00:00:00 EDT 2017","value":"40764.0"},{"date":"Tue Feb 28 00:00:00 EST 2017","value":"40561.0"},{"date":"Tue Jan 31 00:00:00 EST 2017","value":"37874.0"},{"date":"Sat Dec 31 00:00:00 EST 2016","value":"36166.0"},{"date":"Wed Nov 30 00:00:00 EST 2016","value":"35857.0"},{"date":"Mon Oct 31 00:00:00 EDT 2016","value":"34923.0"},{"date":"Fri Sep 30 00:00:00 EDT 2016","value":"37997.0"},{"date":"Wed Aug 31 00:00:00 EDT 2016","value":"37269.0"},{"date":"Sun Jul 31 00:00:00 EDT 2016","value":"39170.0"},{"date":"Thu Jun 30 00:00:00 EDT 2016","value":"36986.0"},{"date":"Tue May 31 00:00:00 EDT 2016","value":"36813.0"},{"date":"Sat Apr 30 00:00:00 EDT 2016","value":"35574.0"},{"date":"Thu Mar 31 00:00:00 EDT 2016","value":"34553.0"},{"date":"Mon Feb 29 00:00:00 EST 2016","value":"33586.0"},{"date":"Sun Jan 31 00:00:00 EST 2016","value":"34314.0"},{"date":"Thu Dec 31 00:00:00 EST 2015","value":"39452.0"},{"date":"Mon Nov 30 00:00:00 EST 2015","value":"39274.0"},{"date":"Sat Oct 31 00:00:00 EDT 2015","value":"37900.0"},{"date":"Wed Sep 30 00:00:00 EDT 2015","value":"35511.0"},{"date":"Mon Aug 31 00:00:00 EDT 2015","value":"38668.0"},{"date":"Fri Jul 31 00:00:00 EDT 2015","value":"41587.0"},{"date":"Tue Jun 30 00:00:00 EDT 2015","value":"40251.0"},{"date":"Sun May 31 00:00:00 EDT 2015","value":"39815.0"},{"date":"Thu Apr 30 00:00:00 EDT 2015","value":"37397.0"},{"date":"Tue Mar 31 00:00:00 EDT 2015","value":"38260.0"},{"date":"Sat Feb 28 00:00:00 EST 2015","value":"37558.0"},{"date":"Sat Jan 31 00:00:00 EST 2015","value":"35947.0"},{"date":"Wed Dec 31 00:00:00 EST 2014","value":"34923.0"},{"date":"Sun Nov 30 00:00:00 EST 2014","value":"34605.0"},{"date":"Fri Oct 31 00:00:00 EDT 2014","value":"33390.0"},{"date":"Tue Sep 30 00:00:00 EDT 2014","value":"31269.0"},{"date":"Sun Aug 31 00:00:00 EDT 2014","value":"31642.0"},{"date":"Thu Jul 31 00:00:00 EDT 2014","value":"30337.0"},{"date":"Mon Jun 30 00:00:00 EDT 2014","value":"30843.0"},{"date":"Sat May 31 00:00:00 EDT 2014","value":"29645.0"},{"date":"Wed Apr 30 00:00:00 EDT 2014","value":"28660.0"},{"date":"Mon Mar 31 00:00:00 EDT 2014","value":"29547.0"},{"date":"Fri Feb 28 00:00:00 EST 2014","value":"30524.0"},{"date":"Fri Jan 31 00:00:00 EST 2014","value":"28625.0"},{"date":"Tue Dec 31 00:00:00 EST 2013","value":"27542.0"},{"date":"Sat Nov 30 00:00:00 EST 2013","value":"26957.0"},{"date":"Thu Oct 31 00:00:00 EDT 2013","value":"25519.0"},{"date":"Mon Sep 30 00:00:00 EDT 2013","value":"24641.0"},{"date":"Sat Aug 31 00:00:00 EDT 2013","value":"23647.0"},{"date":"Wed Jul 31 00:00:00 EDT 2013","value":"24108.0"},{"date":"Sun Jun 30 00:00:00 EDT 2013","value":"22360.0"},{"date":"Fri May 31 00:00:00 EDT 2013","value":"22564.0"},{"date":"Tue Apr 30 00:00:00 EDT 2013","value":"22094.0"},{"date":"Sun Mar 31 00:00:00 EDT 2013","value":"21304.0"},{"date":"Thu Feb 28 00:00:00 EST 2013","value":"20035.0"},{"date":"Thu Jan 31 00:00:00 EST 2013","value":"19796.0"},{"date":"Mon Dec 31 00:00:00 EST 2012","value":"18367.0"},{"date":"Fri Nov 30 00:00:00 EST 2012","value":"18341.0"},{"date":"Wed Oct 31 00:00:00 EDT 2012","value":"18234.0"},{"date":"Sun Sep 30 00:00:00 EDT 2012","value":"18660.0"},{"date":"Fri Aug 31 00:00:00 EDT 2012","value":"17844.0"},{"date":"Tue Jul 31 00:00:00 EDT 2012","value":"17711.0"},{"date":"Sat Jun 30 00:00:00 EDT 2012","value":"17773.0"},{"date":"Thu May 31 00:00:00 EDT 2012","value":"16886.0"},{"date":"Mon Apr 30 00:00:00 EDT 2012","value":"17480.0"},{"date":"Sat Mar 31 00:00:00 EDT 2012","value":"17516.0"},{"date":"Wed Feb 29 00:00:00 EST 2012","value":"16655.0"},{"date":"Tue Jan 31 00:00:00 EST 2012","value":"16380.0"},{"date":"Sat Dec 31 00:00:00 EST 2011","value":"15288.0"},{"date":"Wed Nov 30 00:00:00 EST 2011","value":"15075.0"},{"date":"Mon Oct 31 00:00:00 EDT 2011","value":"15173.0"},{"date":"Fri Sep 30 00:00:00 EDT 2011","value":"14241.0"},{"date":"Wed Aug 31 00:00:00 EDT 2011","value":"15191.0"},{"date":"Sun Jul 31 00:00:00 EDT 2011","value":"15901.0"},{"date":"Thu Jun 30 00:00:00 EDT 2011","value":"16726.0"},{"date":"Tue May 31 00:00:00 EDT 2011","value":"16974.0"},{"date":"Sat Apr 30 00:00:00 EDT 2011","value":"16335.0"},{"date":"Thu Mar 31 00:00:00 EDT 2011","value":"15350.0"},{"date":"Mon Feb 28 00:00:00 EST 2011","value":"14880.0"},{"date":"Mon Jan 31 00:00:00 EST 2011","value":"14463.0"},{"date":"Fri Dec 31 00:00:00 EST 2010","value":"14153.0"},{"date":"Tue Nov 30 00:00:00 EST 2010","value":"13363.0"},{"date":"Sun Oct 31 00:00:00 EDT 2010","value":"13700.0"},{"date":"Thu Sep 30 00:00:00 EDT 2010","value":"13505.0"},{"date":"Tue Aug 31 00:00:00 EDT 2010","value":"12183.0"},{"date":"Sat Jul 31 00:00:00 EDT 2010","value":"12591.0"},{"date":"Wed Jun 30 00:00:00 EDT 2010","value":"12413.0"},{"date":"Mon May 31 00:00:00 EDT 2010","value":"12937.0"},{"date":"Fri Apr 30 00:00:00 EDT 2010","value":"13753.0"},{"date":"Wed Mar 31 00:00:00 EDT 2010","value":"14303.0"},{"date":"Sun Feb 28 00:00:00 EST 2010","value":"13514.0"},{"date":"Sun Jan 31 00:00:00 EST 2010","value":"13523.0"},{"date":"Thu Dec 31 00:00:00 EST 2009","value":"13265.0"},{"date":"Mon Nov 30 00:00:00 EST 2009","value":"12786.0"},{"date":"Sat Oct 31 00:00:00 EDT 2009","value":"11739.0"},{"date":"Wed Sep 30 00:00:00 EDT 2009","value":"12405.0"},{"date":"Mon Aug 31 00:00:00 EDT 2009","value":"12112.0"},{"date":"Fri Jul 31 00:00:00 EDT 2009","value":"11650.0"},{"date":"Tue Jun 30 00:00:00 EDT 2009","value":"10994.0"},{"date":"Sun May 31 00:00:00 EDT 2009","value":"10790.0"},{"date":"Thu Apr 30 00:00:00 EDT 2009","value":"10000.0"}]

 
Growth of $10,000

   

Morningstar Analyst Rating

Bronze

Morningstar awarded the Fund a Bronze analyst rating on 2/25/191

Calendar Year Returns (%)
Fund BENCHMARK
2018 -2.74 6.71
2017 21.94 22.47
2016 -8.33 -2.05
2015 12.97 7.41
2014 26.80 24.79
2013 49.95 42.19
2012 20.14 18.35
2011 8.03 11.88
2010 6.69 5.20
2009 21.74 20.76

Excludes sales charges. If sales charges and taxes had been included, the value would have been lower.

CharacteristicsAllocations, exposures and holdings are subject to change. Percentages may be rounded.

Allocations, exposures and holdings are subject to change. Percentages may be rounded.
Statistics
As of Date 4/30/2019
Net Assets $1.3 billion
# of Holdings 101
% in Equities 94
% in Foreign Equities 15
Beta (3 year) 1.08
R Squared (3 year) 0.85
Standard Deviation 15.49%
Turnover (3/31/2019) 31%
Active Share 64%
Holdings Characteristics
(as of 4/30/2019)
Fund S&P Composite 1500 Health Care Index
Price/Earnings 27.6x 14.1x
Price/Book 4.2x 4.4x
EPS Growth Rate 13.0% 9.1%
Return on Equity -0.9% 20.9%
Asset Weighted Market Cap (billions) $55.3 $124.6
Median Market Cap (billions) $4.7 $4.1
Return Characteristics
(as of 4/30/2019)
Fund
Alpha (5 Year) -1.41
Down Capture (5 Year) 111.97
Information Ratio (5 Year) -0.08
Sharpe Ratio (5 Year) 0.68
Up Capture (5 Year) 104.88
Market Cap Distribution %
(as of 4/30/2019)
Less than $2 billion 13
$2 billion - $5 billion 12
$5 billion - $10 billion 6
Greater than $10 billion 69
Not Classified 0

Regional Exposure (%)

(as of 4/30/2019)
label value
North America 85
Europe 10
Japan 3
Middle East/Developed 1
Emerging Markets 1
(as of 3/31/2019)
label value
North America 85
Europe 10
Japan 3
Middle East/Developed 1
Emerging Markets 1

Top Ten Holdings (%)

(as of 4/30/2019)
label percentageholding
Abbott Laboratories 5.52
UnitedHealth Group, Inc. 4.50
Anthem, Inc. 3.97
Thermo Fisher Scientific, Inc. 3.65
Boston Scientific Corp. 3.33
Medtronic plc 3.28
Bristol-Myers Squibb Co. 3.11
Eli Lilly & Co. 3.09
Danaher Corp. 2.89
Allergan plc 2.78
Total Portfolio % 36.12
(as of 3/31/2019)
label percentageholding
Abbott Laboratories 5.37
UnitedHealth Group, Inc. 4.62
Anthem, Inc. 4.20
Thermo Fisher Scientific, Inc. 3.48
Boston Scientific Corp. 3.33
Eli Lilly & Co. 3.32
Medtronic plc 3.26
Bristol-Myers Squibb Co. 3.09
Danaher Corp. 2.79
Seattle Genetics, Inc. 2.71
Total Portfolio % 36.17
Fund Essentials
Inception Date 05/01/2000
Symbol HGHIX
CUSIP 416649887
Fund Number 1309

Subsector Exposure

(as of 4/30/2019)
label currentpercentage
Medical Technology 30
Health Care Services 21
Biopharma Mid Cap 19
Biopharma Large Cap 18
Biopharma Small Cap 12
(as of 3/31/2019)
label currentpercentage
Medical Technology 28
Health Care Services 21
Biopharma Mid Cap 18
Biopharma Large Cap 20
Biopharma Small Cap 13
Based on sub-adviser's classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.

Insights

pdf

Healthy Skepticism: Is the Market Unfairly Punishing Healthcare Stocks? 

05/15/2019
The political debate over Medicare for All has been a headwind for healthcare stocks and may continue to be in the near term.
pdf

Investable Innovation: Tracking Remarkable Biopharmaceutical Advances 

05/07/2019
In the coming decade, we should witness the arrival of a host of wonderful new drugs and novel treatment modalities.
pdf

2Q19 Multi-Asset Outlook: What's Really Changed? 

04/15/2019
The big question now is how much higher markets can climb on the back of easier policy given that economic fundamentals continue to deteriorate.

Literature

Financial Professionals:

Log in to order forms and literature and manage your subscriptions.

  • Add to favorite(0)
  • Email(0)
  • Add to Cart(0)

Fund Literature

Select All

0 items Selected
My Favorites
Please select at least one item.

Done

pdf

Fact Sheet

03/31/2019 | pdf

This client flyer summarizes the Fund's investment approach, portfolio statistics, top holdings, and current performance.

View FINRA Letter

Add to
Cart

Fund Story

04/24/2019 | pdf

This Fund Story outlines three distinguishing characteristics to help investors better understand the Fund.

View FINRA Letter

Add to
Cart

Commentary

03/31/2019 | pdf

Current quarterly commentary from our sub-adviser, Wellington Management, which includes a performance review, attribution, statistics, and positioning and outlook for the Fund.

View FINRA Letter

Add to
Cart

Expanded Commentary

03/31/2019 | pdf

Current quarterly commentary from our sub-adviser, Wellington Management, which includes a performance review, attribution, statistics, and positioning and outlook for the Fund.

Add to
Cart

Summary Prospectus

03/01/2019 | pdf

A concise summary of the Fund’s investment strategy, performance, expenses, risks, and management team.

Pitchbook

03/31/2019 | pdf

This Pitchbook reviews the Funds' investment approach, investment team, investment process, and general portfolio parameters.

Semi Annual Report

04/30/2018 | pdf

A semi-annual update on the Fund that includes a manager discussion of the Fund’s performance and financial statements.

Statutory Prospectus

03/01/2019 | pdf

An annual update on the Fund that includes information about the Fund’s investment manager, sub-adviser, and operations.

Annual Report

10/31/2018 | pdf

An annual update on the Fund that includes a manager discussion of the Fund’s performance and financial statements.

SAI

03/01/2019 | pdf

A supplementary document to the Fund’s prospectus that includes additional information about the Fund and its operations.  

Important Risks: Investing involves risk, including the possible loss of principal. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political and economic developments. These risks may be greater for investments in emerging markets. • Small- and mid-cap securities can have greater risks and volatility than large-cap securities.

1 The Morningstar Analyst Rating is not a credit or risk rating. It is a subjective evaluation performed by the manager research analysts of Morningstar. Morningstar evaluates funds based on five key pillars, which are process, performance, people, parent, and price. Analysts use this five pillar evaluation to determine how they believe funds are likely to perform over the long term on a risk-adjusted basis. They consider quantitative and qualitative factors in their research, and the weighting of each pillar may vary. The Analyst Rating scale is Gold, Silver, Bronze, Neutral, Negative. A Morningstar Analyst Rating of Gold, Silver, or Bronze reflects an Analyst’s conviction in a fund’s prospects for outperformance. Analyst Ratings are continuously monitored and reevaluated at least every 14 months. The Morningstar Analyst Rating should not be used as the sole basis in evaluating a mutual fund. Morningstar Analyst Ratings involve unknown risks and uncertainties which may cause Morningstar’s expectations not to occur or to differ significantly from what we expected. For more detailed information about Morningstar’s Analyst rating, including its methodology, please go to hartfordfunds.com/MorningstarAnalystMethodology.

212244    210715